"DNA Adducts" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The products of chemical reactions that result in the addition of extraneous chemical groups to DNA.
| Descriptor ID |
D018736
|
| MeSH Number(s) |
D13.444.308.135 G05.200.104
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "DNA Adducts".
Below are MeSH descriptors whose meaning is more specific than "DNA Adducts".
This graph shows the total number of publications written about "DNA Adducts" by people in this website by year, and whether "DNA Adducts" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 0 | 1 | 1 |
| 2004 | 1 | 0 | 1 |
| 2006 | 0 | 1 | 1 |
| 2018 | 0 | 1 | 1 |
| 2019 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "DNA Adducts" by people in Profiles.
-
South AP, den Breems NY, Richa T, Nwagu U, Zhan T, Poojan S, Martinez-Outschoorn U, Johnson JM, Luginbuhl AJ, Curry JM. Mutation signature analysis identifies increased mutation caused by tobacco smoke associated DNA adducts in larynx squamous cell carcinoma compared with oral cavity and oropharynx. Sci Rep. 2019 12 17; 9(1):19256.
-
Schug ZT. Formaldehyde Detoxification Creates a New Wheel for the Folate-Driven One-Carbon "Bi"-cycle. Biochemistry. 2018 02 13; 57(6):889-890.
-
Brown DB, Cai SR, Fundakowski CE, Zamboni WC, Strychor S, McLeod HL. Pharmacokinetics after endovascular lung perfusion with Cisplatin. J Vasc Interv Radiol. 2006 May; 17(5):883-8.
-
Brown DB, Ma MK, Battafarano RJ, Naidu S, Pluim D, Zamboni WC, McLeod HL. Endovascular lung perfusion using high-dose cisplatin: uptake and DNA adduct formation in an animal model. Oncol Rep. 2004 Jan; 11(1):237-43.
-
Adjei AA, Reid JM, Erlichman C, Sloan JA, Pitot HC, Alberts SR, Goldberg RM, Hanson LJ, Ruben S, Boemer SA, Atherton P, Ames MM, Kaufmann SH. A phase I and pharmacologic study of pyrazoloacridine (NSC 366140) and carboplatin in patients with advanced cancer. Invest New Drugs. 2002 Aug; 20(3):297-304.